SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
Feb 23, 2022
Document Date
Feb 18, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Chinook Therapeutics, Inc.
Issuer
CHINOOK THERAPEUTICS, INC.
Filer
KING ANDREW JAMES

IR Contact

Novartis Investor Relations

investor.relations@novartis.com

 

MEDIA CONTACT

Novartis Media Relations

media.relations@novartis.com